TEXAS VIRTUAL MPN WORKSHOP: Module VI
Novel Pathways and Targets in MPNs: Moving Beyond JAKi
Presentations
Myeloproliferative Neoplasms: Context, Pathways and Targets
Alison Moliterno, MD, Johns Hopkins Medicine, Baltimore, MD
28 August, 2020
Targeted Therapies in Combination with JAK Inhibitor
Lucia Masarova, MD, UT MD Anderson Cancer Center, Houston, TX
28 August, 2020
Novel Targeted Therapies Beyond JAK Inhibitors
Naveen Pemmaraju, MD, UT MD Anderson Cancer Center, Houston, TX
28 August, 2020